Table 5.
Summary of biological compounds targeting the PI3K/AKT pathway for attenuating liver fibrosis.
| Compound | In vitro activation | In vivo activation | Human activity | Reference |
|---|---|---|---|---|
| Erythropoietin (EPO) | Not assessed | Yes - rat | Not assessed | (149) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.